January 2, 2014
Kick Off 2014 in Doha, Qatar with
Updates on Immunotherapy of Cancer and Immunoscore
|
|
|
*Four Seasons Hotel, site of the 2014 meeting. For more information, please visit Four Seasons Hotel's official site.
This symposium provides an educational environment focused on improving the outcome for patients with cancer by incorporating strategies based on cancer immunotherapy. With leading authorities in tumor immunology and cancer immunotherapy, as well as oral abstract and poster presenters, this program will describe the latest research advances, focus on currently approved and emerging tumor immunotherapy approaches, provide highlights on SITC initiatives and projects, and offer updates on international initiatives, including the Immunoscore.
|
Intended Audience Are you involved in cancer research and/or wish to learn more about advances in cancer immunology and immunotherapy? Our target audience consists of basic and clinical investigators from academic institutions as well as industry and regulatory agencies including:
|
Topics
*denotes non-abstract category
|
This meeting provides you the opportunity to:
- Contrast the efficacy and adaptability of distinct immunotherapeutic strategies and pursue opportunities for integrating them
- Identify global cancer immunotherapy initiatives and assess their impact on and growth in local practice
- Investigate how to integrate immunotherapeutic approaches for cancer treatment into current conventional regimens to increase clinical benefit
- Share data and ideas on the most recent preclinical and clinical advances in tumor immunology and cancer immunotherapy
Jointly-Sponsored by Sidra Medical and Research Center and Society for Immunotherapy of Cancer:
